MEDSTONE STS LITHOTRIPTER

Lithotripter, Shockwave (for Treating Gallbladder Stones)

FDA Premarket Approval P970042 S002

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for 1) the use of two generic ursodiols, one manufactured by amide pharmaceutical and one by teva pharmaceutical, in addition to actigall; 2) a change in the post-approval study's medical monitor to joan l. Drucker m. D. , r. S. I. ; and 3) several minor clarifications, corrections and editorial changes to the post-approval study protocol. The device, as modified, will be marketed under the same trade name, medstone sts lithotripter, and is indicated for the treatment of symptomatic, solitary, radiolucent, non-calcified gallstones (between 4 and 20 mm in maximum diameter) in adults patients for whom surgical removal of the gallbladder is medically contraindicated and in symptomatic high-risk patients who have actively refused surgery. Combination therapy consists of 1)administration of novartis pharmaceutical actigall, or amide pharmaceutical ursodiol, or teva pharmaceutical ursodiol (8-10 mg/kg/day) for at least two weeks pre-lithotripsy, 2) lithotripsy treatments of up to 2000 24 kv shocks, and 3) continued administration of ursodiol until a stone-free state is achieved.

DeviceMEDSTONE STS LITHOTRIPTER
Classification NameLithotripter, Shockwave (for Treating Gallbladder Stones)
Generic NameLithotripter, Shockwave (for Treating Gallbladder Stones)
ApplicantMEDSTONE INTL., INC.
Date Received2002-02-21
Decision Date2002-08-20
PMAP970042
SupplementS002
Product CodeNCV
Advisory CommitteeGastroenterology/Urology
Supplement TypeNormal 180 Day Track
Supplement ReasonLabeling Change - Indications/instructions/shelf Life/tradename
Expedited ReviewNo
Combination Product Yes
Applicant Address MEDSTONE INTL., INC. 100 Columbia, Suite 100 aliso Viejo, CA 92656-4114

Supplemental Filings

Supplement NumberDateSupplement Type
P970042Original Filing
S004 2002-08-02 Normal 180 Day Track
S003 2002-07-03 Normal 180 Day Track
S002 2002-02-21 Normal 180 Day Track
S001 2000-12-18 Normal 180 Day Track

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.